Law Sites
APRIL 11, 2024
While the last few years have brought an abundance of new and innovative legal tech products to market, the fact of the matter is that not every new product will succeed. Inevitably, for whatever reason, some products fail. But one thing for certain is that while some products shut down with a whimper, others go out with a bang. Let’s revisit five of the most momentous legal tech fails of the last 10 years. 1.
Attorney at Work
APRIL 11, 2024
The Planetary Lawyer Project’s Matthew Karmel talks with Alex Su, Amee Vanderpool, Chris Harvey, Jonah Perlin and Albert Tawil about building a successful attorney newsletter in your niche. The business community knows the value and staying power of newsletters: Recent studies show the return on investment for email marketing is $36 for every $1 spent. […] The post Attorney Newsletters: Six Lawyers Tell How They Built the Best Newsletters in Their Niche appeared first on Articles, Tips and
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lawmatics
APRIL 11, 2024
April Fools’ Day may have been last week, but these new features are no joke. We’ve got a trio of updates for managing your matters, calendars, and finances. You’ll also find some quality-of-life tweaks that’ll simplify things for our intake coordinators and office managers out there. Filter and sort your table of matters We've revamped our classic matter table for a smoother user experience.
IP Watchdog
APRIL 11, 2024
On April 9, Representative Adam Schiff (D-CA) introduced the Generative AI Copyright Disclosure Act of 2024 into the U.S. House of Representatives. The bill, which would require generative artificial intelligence (AI) platforms to disclose their use of copyrighted works in training AI models with retroactive effect, comes after months of growing concerns by the global creative community over the misappropriation of original works of authorship by companies collecting such content without prior a
Advertiser: Trellis
Law Firm Intelligence by Trellis aggregates state trial court data across the Trellis platform enabling users to: look up a particular metric related to a specific law firm (such as, how many cases a law firm had or has against another law firm), and see the actual dockets and documents supporting the metric. Trellis data is maximized in a revolutionary and unique way to provide users an exclusive look into a law firm litigating in state trial courts.
IP Watchdog
APRIL 11, 2024
On April 9, Knowledge Ecology International (KEI), the Union for Affordable Cancer Treatment (UACT) and Universities Allied for Essential Medicines (UAEM) sent a letter to Chiquita Brooks-LaSure, Administrator for the Centers for Medicare and Medicaid Services, requesting that CMS use alleged statutory authority to allow companies to make and sell generic versions of the blockbuster prostate cancer drug, Xtandi®.
IP Watchdog
APRIL 11, 2024
In a precedential decision authored by Judge Lourie, the U.S. Court of Appeals for the Federal Circuit affirmed a district court’s final judgment that certain claims of several patents owned by Salix Pharmaceuticals for a drug used to treat irritable bowel syndrome (IBS) and other ailments were invalid as obvious. The CAFC also affirmed an order of the district court that instructed the Food and Drug Administration (FDA) that the effective approval date of generic company Norwich’s Abbreviated N
Expert insights. Personalized for you.
329 
Let's personalize your content